Page last updated: 2024-08-23

lovastatin and Glomerulosclerosis, Focal Segmental

lovastatin has been researched along with Glomerulosclerosis, Focal Segmental in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19903 (27.27)18.7374
1990's8 (72.73)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aguilar-Salinas, CA; Barrett, PH; Delmez, J; Kelber, J; Schonfeld, G1
Bahner, U; Heidland, A; Paczek, L; Schaefer, L; Schaefer, RM; Teschner, M1
Keane, WF1
Han, DC; Hwang, SD; Jin, SY; Lee, HB; Lee, SK1
Fujishima, M; Nanishi, F; Okuda, S; Onoyama, K; Washio, M1
Neugarten, J; Rubin, R; Sablay, L; Silbiger, S1
Kasiske, BL; Keane, WF; Kim, Y; O'Donnell, MP; Schmitz, PG1
Harris, KP; Klahr, S; Purkerson, ML; Yates, J1
Garvis, WJ; Kasiske, BL; Keane, WF; O'Donnell, MP1
Cleary, MP; Kasiske, BL; Keane, WF; O'Donnell, MP1
Kasiske, BL; Keane, WF; O'Donnell, MP1

Reviews

1 review(s) available for lovastatin and Glomerulosclerosis, Focal Segmental

ArticleYear
Lipids and the kidney.
    Kidney international, 1994, Volume: 46, Issue:3

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Blood Pressure; Glomerulosclerosis, Focal Segmental; Humans; Hyperlipidemias; Kidney Failure, Chronic; Lovastatin; Male; Proteinuria

1994

Trials

1 trial(s) available for lovastatin and Glomerulosclerosis, Focal Segmental

ArticleYear
Physiologic mechanisms of action of lovastatin in nephrotic syndrome.
    Journal of lipid research, 1995, Volume: 36, Issue:1

    Topics: Apolipoproteins; Apolipoproteins B; Cholesterol, LDL; Double-Blind Method; Glomerulosclerosis, Focal Segmental; Humans; Hyperlipidemias; Kinetics; Lipids; Lipoproteins; Lipoproteins, IDL; Lipoproteins, LDL; Lipoproteins, VLDL; Lovastatin; Male; Placebos; Triglycerides

1995

Other Studies

9 other study(ies) available for lovastatin and Glomerulosclerosis, Focal Segmental

ArticleYear
Lovastatin ameliorates depressed intraglomerular proteolytic activities in experimental nephrotic syndrome.
    Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1994, Volume: 194, Issue:6

    Topics: Albuminuria; Animals; Doxorubicin; Endopeptidases; Glomerulosclerosis, Focal Segmental; Hyperlipidemias; Kidney Glomerulus; Lovastatin; Male; Nephrotic Syndrome; Proteinuria; Rats; Rats, Inbred Lew

1994
Effects of delayed treatment with enalapril and/or lovastatin on the progression of glomerulosclerosis in 5/6 nephrectomized rats.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1993, Volume: 8, Issue:12

    Topics: Animals; Blood Pressure; Blood Urea Nitrogen; Body Weight; Cholesterol; Enalapril; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Lovastatin; Male; Nephrectomy; Proteinuria; Rats; Rats, Sprague-Dawley; Systole; Triglycerides

1993
Effects of anti-hyperlipidaemic agent or dietary protein restriction on progressive renal deterioration in adriamycin-induced nephropathy in rats.
    International urology and nephrology, 1993, Volume: 25, Issue:3

    Topics: Animals; Blood Urea Nitrogen; Body Weight; Cholesterol; Creatinine; Dietary Proteins; Doxorubicin; Glomerulosclerosis, Focal Segmental; Lovastatin; Male; Models, Biological; Proteinuria; Rats; Rats, Inbred Lew; Triglycerides

1993
Combined antihypertensive and lipid-lowering therapy in experimental glomerulonephritis.
    Hypertension (Dallas, Tex. : 1979), 1994, Volume: 23, Issue:1

    Topics: Animals; Antihypertensive Agents; Cholesterol; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Hyperlipidemias; Hypertension; Lovastatin; Male; Rats; Rats, Sprague-Dawley

1994
Lovastatin retards the progression of established glomerular disease in obese Zucker rats.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1993, Volume: 22, Issue:1

    Topics: Animals; Cell Division; Cells, Cultured; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Hyperlipidemias; Lovastatin; Male; Obesity; Rats; Rats, Zucker; Time Factors

1993
Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1990, Volume: 15, Issue:1

    Topics: Animals; Blood Urea Nitrogen; Cholesterol; Female; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Hypercholesterolemia; Kidney Glomerulus; Lovastatin; Nephrotic Syndrome; Rats; Rats, Inbred Strains; Uremia

1990
Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure.
    Circulation research, 1988, Volume: 62, Issue:2

    Topics: Animals; Cholesterol; Clofibrate; Clofibric Acid; Disease Models, Animal; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Hyperlipidemias; Kidney; Kidney Failure, Chronic; Kidney Glomerulus; Lovastatin; Male; Nephrectomy; Nephrons; Rats; Rats, Inbred Strains; Triglycerides

1988
Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats.
    Kidney international, 1988, Volume: 33, Issue:3

    Topics: Albuminuria; Animals; Cholesterol; Clofibrate; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Hyperlipidemias; Lovastatin; Male; Obesity; Rats; Rats, Zucker; Triglycerides

1988
The role of lipids in progressive glomerular disease.
    Advances in experimental medicine and biology, 1987, Volume: 223

    Topics: Animals; Clofibric Acid; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Humans; Hyperlipidemias; Hypertension, Renal; Lipid Metabolism; Lovastatin; Rats; Rats, Zucker

1987